Cooperative Agreement U54CK000162

The University of Washington (UW) was awarded a $12,516,366 Cooperative Agreement from the National Center for Immunization and Respiratory Diseases (NCIRD), part of the U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC). The award, titled "SEAPREP: SEATTLE PANDEMIC PREPAREDNESS COHORT" (CFDA 93.354 - Public Health Emergency Response: Cooperative Agreement for Emergency Response), will support UW in rapidly mobilizing and responding to...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $3,000,000 Cooperative Agreement under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) to Emory University. The award, valid from September 30, 2024 to September 29, 2029, supports the Emory Prevention Research Center to conduct research, interventions, and public health initiatives related to chronic disease prevention and management. The award involves sub-grants to Baylor College of Medicine...

The Washington State Department of Health (DOH) and Public Health Seattle-King County (PHSKC) were awarded a 5-year, $15,344,203 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The purpose is to implement high-impact HIV prevention, surveillance, and treatment strategies across Washington state, with a focus on reaching disproportionately impacted populations. Key activities include...

The Washington State Department of Health received a $4,679,110 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Public Health Emergency Response: Cooperative Agreement for Emergency Response (CFDA 93.354) program. The funding supports the department's "quilt of capability" framework, which enables rapid mobilization and response to significant public health emergencies that overwhelm local jurisdictional resources in Washington state. The...

This Project Grant award of $231,700.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop novel biologics to treat Staphylococcus aureus (S. aureus) infections, including methicillin-resistant S. aureus (MRSA). The key objectives are to: 1) characterize the binding properties and neutralization capacity of engineered DARPin (D) proteins against a panel of S. aureus isolates, 2)...

The Department of Health and Human Services Agency for Healthcare Research and Quality awarded Oregon State University a $740,620 Project Grant under the Research on Healthcare Costs, Quality and Outcomes program (CFDA 93.226) to evaluate the integration of state prescription drug monitoring programs into electronic health records. Oregon Health & Science University and Comagine Health were named as sub-awardees to provide integration services for OHSU's Epic EHR system and support...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $146,922 to the University of Washington to conduct research on strategies to prevent chlamydia infections. The key products and services to be delivered under this award include: 1) Characterizing the frequency and factors associated with antibiotic use for prevention of chlamydia infections among men who have sex...

This Cooperative Agreement award from the U.S. Environmental Protection Agency (EPA) under the Brownfields Job Training Cooperative Agreements program (CFDA 66.815) provides $500,000 in funding to St. Louis Community College for a 5-year project. The primary objective is to recruit, train, and place unemployed and underemployed residents of St. Louis City, St. Louis County, and East St. Louis, Illinois in environmental careers. The project will train 88 participants, graduate 79, and place at...

The Centers for Disease Control and Prevention (CDC) awarded a $1,524,000 Cooperative Agreement under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421) to The Johns Hopkins University. The five-year award, effective September 30, 2024, will support the university's work as the Region 3 Center for Public Health Preparedness and Response. Key activities include building capacity within governmental,...

This federal Project Grant award totaling $810,312.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research to investigate environmental reservoirs and transmission dynamics of multi-drug resistant Enterobacterales (MDR ENT) in the Chicago area. The key objectives are to: 1) Profile MDR ENT and mobile antibiotic resistance genes in Greater Chicago waterways to identify environmental...